Valuation: FDC Limited

Market Cap 52.29B 554M 487M 449M 419M 787M 801M 5.38B 2.08B 25.78B 2.08B 2.04B 89.58B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 500M 439M 404M 378M 709M 722M 4.85B 1.88B 23.24B 1.88B 1.84B 80.76B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.57%
1 week+6.27%
Current month+0.81%
1 month+10.55%
3 months+23.76%
6 months-0.21%
Current year-3.50%
1 week 387.15
Extreme 387.15
421.5
1 month 373.25
Extreme 373.25
439.45
Current year 312.95
Extreme 312.95
439.45
1 year 312.95
Extreme 312.95
527.8
3 years 306.55
Extreme 306.55
658.85
5 years 225
Extreme 225
658.85
10 years 148.3
Extreme 148.3
658.85
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 63 30/09/1993
Director/Board Member 48 31/12/2001
Director/Board Member 84 15/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.57%+6.27% - - 706M
+6.03%+7.45%+48.94%+161.56% 1,006B
+3.34%+9.63%+66.81%+54.96% 589B
+1.89%+8.28%+33.34%+84.56% 430B
-0.66%+5.11%+29.26%+21.27% 331B
+1.41%+7.80%+40.64%+26.34% 288B
-0.44%+6.05%+30.66%+41.09% 285B
+0.73%+8.53%-26.22%-40.85% 213B
+2.01%+4.61%+29.20%+60.46% 190B
+2.27%+1.89%+18.22%+66.18% 154B
Average +1.60%+5.96%+30.09%+52.84% 387.31B
Weighted average by Cap. +2.81%+5.38%+38.96%+77.60%

Financials

2024 2025
Net sales 19.43B 206M 181M 167M 156M 292M 298M 2B 774M 9.58B 773M 756M 33.28B 21.08B 223M 196M 181M 169M 317M 323M 2.17B 840M 10.39B 839M 821M 36.11B
Net income 3.05B 32.35M 28.41M 26.18M 24.48M 45.91M 46.75M 314M 122M 1.5B 121M 119M 5.23B 2.67B 28.27M 24.84M 22.88M 21.39M 40.13M 40.86M 275M 106M 1.32B 106M 104M 4.57B
Net Debt -4.55B -48.21M -42.35M -39.02M -36.48M -68.42M -69.68M -468M -181M -2.24B -181M -177M -7.79B -5.15B -54.57M -47.94M -44.17M -41.3M -77.45M -78.87M -530M -205M -2.54B -205M -200M -8.82B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
25/06/26 ₹408.30 -0.57% 218,868
24/06/26 ₹410.65 -0.35% 412,325
23/06/26 ₹412.10 +2.13% 1,013,084
22/06/26 ₹403.50 +3.63% 449,704
19/06/26 ₹389.35 +1.34% 138,399
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B